BEST BUY CO INC, 10-Q filed on 9/5/2025
Quarterly Report
v3.25.2
Cover Page - shares
 6 Months Ended
Aug. 02, 2025
Sep. 03, 2025
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Aug. 02, 2025  
Document Transition Report false  
Entity File Number 1-9595  
Entity Registrant Name BEST BUY CO., INC.  
Entity Incorporation, State or Country Code MN  
Entity Tax Identification Number 41-0907483  
Entity Address, Address Line One 7601 Penn Avenue South  
Entity Address, City or Town Richfield  
Entity Address, State or Province MN  
Entity Address, Postal Zip Code 55423  
City Area Code 612  
Local Phone Number 291-1000  
Title of 12(b) Security Common Stock, $0.10 par value per share  
Trading Symbol BBY  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   210,101,265
Entity Central Index Key 0000764478  
Amendment Flag false  
Current Fiscal Year End Date --01-31  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2026  
v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Aug. 02, 2025
Feb. 01, 2025
 [1]
Aug. 03, 2024
Current assets      
Cash and cash equivalents $ 1,456 $ 1,578 $ 1,387
Receivables, net 917 1,044 871
Merchandise inventories 5,816 5,085 5,706
Other current assets 688 517 598
Total current assets 8,877 8,224 8,562
Property and equipment, net 2,046 2,122 2,183
Operating lease assets 2,816 2,833 2,860
Goodwill 908 908 1,383
Other assets 606 695 636
Total assets 15,253 14,782 15,624
Current liabilities      
Accounts payable 5,682 4,980 5,542
Accrued compensation and related expenses 448 464 347
Accrued liabilities 684 741 756
Current portion of operating lease liabilities 610 617 610
Current portion of long-term debt 10 10 13
Total current liabilities 8,553 8,016 8,451
Long-term operating lease liabilities 2,292 2,282 2,316
Long-term debt 1,164 1,144 1,157
Long-term liabilities 528 532 593
Contingencies (Note 10)
Equity      
Preferred stock, $1.00 par value: Authorized - 400,000 shares; Issued and outstanding - none 0 0 0
Common stock, $0.10 par value: Authorized - 1.0 billion shares; Issued and outstanding - XXX.X million, 211.4 million and 215.0 million shares, respectively 22 22 22
Additional paid-in capital 0 0 0
Retained earnings 2,381 2,486 2,775
Accumulated other comprehensive income 313 300 310
Total equity 2,716 2,808 3,107
Total liabilities and equity 15,253 14,782 15,624
Unredeemed gift card liabilities      
Current liabilities      
Short-term contract liabilities included in: 230 253 243
Deferred revenue      
Current liabilities      
Short-term contract liabilities included in: $ 889 $ 951 $ 940
[1] The Consolidated Balance Sheet as of February 1, 2025, has been condensed from the audited consolidated financial statements.
v3.25.2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Aug. 02, 2025
Feb. 01, 2025
Aug. 03, 2024
Statement of Financial Position [Abstract]      
Preferred stock, par value (in dollars per share) $ 1.00 $ 1.00 $ 1.00
Preferred stock, authorized shares (in shares) 400,000 400,000 400,000
Preferred stock, issued shares (in shares) 0 0 0
Preferred stock, outstanding shares (in shares) 0 0 0
Common stock, par value (in dollars per share) $ 0.10 $ 0.10 $ 0.10
Common stock, authorized shares (in shares) 1,000,000,000.0 1,000,000,000.0 1,000,000,000.0
Common stock, issued shares (in shares) 210,400,000 211,400,000 215,000,000.0
Common stock, outstanding shares (in shares) 210,400,000 211,400,000 215,000,000.0
v3.25.2
Condensed Consolidated Statements of Earnings - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Aug. 02, 2025
Aug. 03, 2024
Income Statement [Abstract]        
Revenue $ 9,438 $ 9,288 $ 18,205 $ 18,135
Cost of sales 7,244 7,102 13,962 13,885
Gross profit 2,194 2,186 4,243 4,250
Selling, general and administrative expenses 1,829 1,810 3,550 3,547
Restructuring charges 114 (7) 223 8
Operating income 251 383 470 695
Other income (expense):        
Loss on disposal of subsidiaries (4) 0 (4) 0
Investment income and other 18 21 33 46
Interest expense (12) (13) (24) (25)
Earnings before income tax expense and equity in income of affiliates 253 391 475 716
Income tax expense 68 101 87 181
Equity in income of affiliates 1 1 0 2
Net earnings $ 186 $ 291 $ 388 $ 537
Basic earnings per share (in dollars per share) $ 0.88 $ 1.35 $ 1.83 $ 2.49
Diluted earnings per share (in dollars per share) $ 0.87 $ 1.34 $ 1.82 $ 2.47
Weighted-average common shares outstanding:        
Basic (in shares) 211.5 216.0 211.8 216.1
Diluted (in shares) 212.0 217.1 212.5 217.2
v3.25.2
Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Aug. 02, 2025
Aug. 03, 2024
Statement of Comprehensive Income [Abstract]        
Net earnings $ 186 $ 291 $ 388 $ 537
Foreign currency translation adjustments, net of tax 0 (2) 13 (7)
Comprehensive income $ 186 $ 289 $ 401 $ 530
v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Operating activities    
Net earnings $ 388 $ 537
Adjustments to reconcile net earnings to total cash provided by operating activities:    
Depreciation and amortization 422 437
Restructuring charges 223 8
Stock-based compensation 75 74
Deferred income taxes 45 10
Loss on disposal of subsidiaries 4 0
Other, net 4 2
Changes in operating assets and liabilities:    
Receivables 123 66
Merchandise inventories (717) (761)
Other assets (24) (11)
Accounts payable 693 904
Income taxes (167) (183)
Other liabilities (286) (266)
Total cash provided by operating activities 783 817
Investing activities    
Additions to property and equipment (341) (335)
Disposal of subsidiary (27) 0
Other, net (1) (17)
Total cash used in investing activities (369) (352)
Financing activities    
Repurchase of common stock (165) (148)
Dividends paid (403) (405)
Other, net (6) (4)
Total cash used in financing activities (574) (557)
Effect of exchange rate changes on cash and cash equivalents 5 (3)
Decrease in cash, cash equivalents and restricted cash (155) (95)
Cash, cash equivalents and restricted cash at beginning of period 1,868 1,793
Cash, cash equivalents and restricted cash at end of period $ 1,713 $ 1,698
v3.25.2
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balances (in shares) at Feb. 03, 2024   215.4      
Beginning balance at Feb. 03, 2024 $ 3,053 $ 22 $ 31 $ 2,683 $ 317
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings 537     537  
Other comprehensive income:          
Foreign currency translation adjustments, net of tax (7)       (7)
Stock-based compensation 74   74    
Issuance of common stock (in shares)   1.4      
Issuance of common stock 5   5    
Common stock dividends (405)   9 (414)  
Repurchase of common stock (in shares)   (1.8)      
Repurchase of common stock (150)   (119) (31)  
Ending balances (in shares) at Aug. 03, 2024   215.0      
Ending balance at Aug. 03, 2024 3,107 $ 22 0 2,775 310
Beginning balances (in shares) at May. 04, 2024   216.1      
Beginning balance at May. 04, 2024 3,082 $ 22 26 2,722 312
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings 291     291  
Other comprehensive income:          
Foreign currency translation adjustments, net of tax (2)       (2)
Stock-based compensation 36   36    
Issuance of common stock 1   1    
Common stock dividends (203)   4 (207)  
Repurchase of common stock (in shares)   (1.1)      
Repurchase of common stock (98)   (67) (31)  
Ending balances (in shares) at Aug. 03, 2024   215.0      
Ending balance at Aug. 03, 2024 3,107 $ 22 0 2,775 310
Beginning balances (in shares) at Feb. 01, 2025   211.4      
Beginning balance at Feb. 01, 2025 2,808 $ 22 0 2,486 300
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings 388     388  
Other comprehensive income:          
Foreign currency translation adjustments, net of tax 13       13
Stock-based compensation 75   75    
Issuance of common stock (in shares)   1.5      
Issuance of common stock 2   2    
Common stock dividends (403)   10 (413)  
Repurchase of common stock (in shares)   (2.5)      
Repurchase of common stock (167)   (87) (80)  
Ending balances (in shares) at Aug. 02, 2025   210.4      
Ending balance at Aug. 02, 2025 2,716 $ 22 0 2,381 313
Beginning balances (in shares) at May. 03, 2025   211.3      
Beginning balance at May. 03, 2025 2,763 $ 22 0 2,428 313
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings 186     186  
Other comprehensive income:          
Foreign currency translation adjustments, net of tax 0        
Stock-based compensation 35   35    
Common stock dividends (201)   4 (205)  
Repurchase of common stock (in shares)   (0.9)      
Repurchase of common stock (67)   (39) (28)  
Ending balances (in shares) at Aug. 02, 2025   210.4      
Ending balance at Aug. 02, 2025 $ 2,716 $ 22 $ 0 $ 2,381 $ 313
v3.25.2
Condensed Consolidated Statements of Changes in Shareholders' Equity (Parenthetical) - $ / shares
 3 Months Ended 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Aug. 02, 2025
Aug. 03, 2024
Statement of Stockholders' Equity [Abstract]        
Common stock dividends (in dollars per share) $ 0.95 $ 0.94 $ 1.90 $ 1.88
v3.25.2
Basis of Presentation
 6 Months Ended
Aug. 02, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation Basis of Presentation
Unless the context otherwise requires, the terms “Best Buy,” “we,” “us”, “our” and the “company” in these Notes to Condensed Consolidated Financial Statements refer to Best Buy Co., Inc. and, as applicable, its consolidated subsidiaries.

In the opinion of management, the accompanying condensed consolidated financial statements contain all adjustments necessary for a fair presentation as prescribed by accounting principles generally accepted in the U.S. (“GAAP”). All adjustments were comprised of normal recurring adjustments, except as noted in these Notes to Condensed Consolidated Financial Statements.

A large proportion of our revenue and earnings is generated in the fiscal fourth quarter, which includes the majority of the holiday shopping season. Due to the seasonal nature of our business, interim results are not necessarily indicative of results for the entire fiscal year. The interim financial statements and the related notes included in this Quarterly Report on Form 10-Q should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended February 1, 2025. The first six months of fiscal 2026 and fiscal 2025 each included 26 weeks.

In preparing the accompanying condensed consolidated financial statements, we evaluated the period from August 2, 2025, through the date the financial statements were issued for material subsequent events requiring recognition or disclosure. No such events were identified.

Recently Issued Accounting Pronouncements

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires disclosure of specific categories meeting a quantitative threshold within the income tax rate reconciliation, as well as disaggregation of income taxes paid by jurisdiction. This ASU, which can be applied either prospectively or retrospectively, is effective for annual periods beginning after December 15, 2024, with early adoption permitted. We are currently evaluating the impact of the ASU and expect to include updated income tax disclosures in our fiscal 2026 Form 10-K.

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure of specific expense categories in the notes to financial statements. The amendments are effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. We are currently evaluating the impact of the ASU and expect to include updated expense disclosures in our fiscal 2028 Form 10-K.

Recently Enacted Tax Legislation

On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (“OB3”). The OB3 extends key provisions of the 2017 Tax Cuts and Jobs Act, including, but not limited to, domestic research expensing, 100% bonus depreciation on tangible property and modifications to the international tax framework. The provisions will not have a material impact on our income tax expense.

Supply Chain Financing

We have a supply chain financing program with an independent financial institution, whereby some of our suppliers have the opportunity to receive accounts payable settlements early, at a discount, facilitated by the financial institution. Our liability associated with the funded participation in the program, which is primarily included in Accounts payable on our Condensed Consolidated Balance Sheets, was $872 million, $398 million and $729 million as of August 2, 2025, February 1, 2025, and August 3, 2024, respectively.

Total Cash, Cash Equivalents and Restricted Cash

Cash, cash equivalents and restricted cash reported on our Condensed Consolidated Balance Sheets are reconciled to the totals shown on our Condensed Consolidated Statements of Cash Flows as follows ($ in millions):
August 2, 2025February 1, 2025August 3, 2024
Cash and cash equivalents$1,456$1,578$1,387
Restricted cash included in Other current assets257290311
Total cash, cash equivalents and restricted cash$1,713$1,868$1,698
Amounts included in restricted cash are primarily restricted to cover product protection plans provided under our membership offerings and self-insurance liabilities.

Reclassification

Certain reclassifications of immaterial amounts previously reported have been made to the accompanying Condensed Consolidated Statements of Cash Flows to maintain consistency and comparability between periods presented.
v3.25.2
Restructuring
 6 Months Ended
Aug. 02, 2025
Restructuring and Related Activities [Abstract]  
Restructuring Restructuring
Restructuring charges were as follows ($ in millions):
Three Months EndedSix Months Ended
August 2, 2025August 3, 2024August 2, 2025August 3, 2024
Fiscal 2026 Labor and Store Optimization Initiative$122$-$122$-
Best Buy Health Optimization and China Sourcing Initiative(6)-105-
Fiscal 2024 Restructuring Initiative(2)(6)(4)10
Fiscal 2023 Resource Optimization Initiative-(1)-(2)
Total$114$(7)$223$8

Fiscal 2026 Labor and Store Optimization Initiative

In the second quarter of fiscal 2026, we commenced a restructuring initiative intended to align field resources with changing customer behaviors, close select non-traditional store locations and redirect corporate resources for better alignment with our strategy. We currently do not expect to incur material future restructuring charges related to this initiative.

All charges incurred related to this initiative were from continuing operations and presented within Restructuring charges on our Condensed Consolidated Statements of Earnings. The composition of restructuring charges incurred related to this initiative were as follows ($ in millions):
Three Months Ended
DomesticInternationalTotal
Termination benefits$78$3$81
Asset impairments(1)
41-41
Total$119$3$122
(1)Represents asset impairments primarily related to planned store closures, including an impairment related to an indefinite-lived tradename. See Note 3, Goodwill and Intangible Assets, for additional information. The remaining carrying value of net assets approximates fair value and was immaterial as of August 2, 2025.

There were no cash payments related to this initiative during the second quarter of fiscal 2026. Our restructuring accrual liabilities related to termination benefits of $81 million as of August 2, 2025, reflect expected future cash payments primarily during fiscal 2026.

Best Buy Health Optimization and China Sourcing Initiative

In the first quarter of fiscal 2026, we commenced a restructuring initiative primarily focused on optimizing our Best Buy Health business by taking actions to maximize value and improve profitability in light of its performance against our original forecasting. These actions included the exit of a component of our Best Buy Health business that was finalized during the second quarter of fiscal 2026. In addition, we also made significant changes to reduce our exposure to tariffs, particularly in China. We currently do not expect to incur material future restructuring charges related to this initiative.
All charges incurred related to this initiative were from continuing operations in our Domestic segment and presented within Restructuring charges on our Condensed Consolidated Statements of Earnings. The composition of restructuring charges incurred related to this initiative were as follows ($ in millions):
Three Months EndedSix Months Ended
August 2, 2025August 2, 2025
Asset impairments and other costs(1)
$(3)$70
Termination benefits(3)35
Total$(6)$105
(1)Primarily represents the full impairment of net assets related to a component of our Best Buy Health business and other exit costs. The remaining carrying value of net assets approximates fair value and was immaterial as of August 2, 2025.

Restructuring accrual activity related to this initiative was as follows ($ in millions):
Termination BenefitsAsset Impairments and Other CostsTotal
Balances at February 1, 2025$-$-$-
Charges382866
Cash payments(9)(27)(36)
Adjustments(1)
(3)(1)(4)
Balances at August 2, 2025$26$-$26
(1)Primarily represents adjustments for termination benefits primarily related to higher-than-expected employee retention from previously planned organizational changes.

Our restructuring accrual liabilities related to termination benefits of $26 million as of August 2, 2025, reflect expected future cash payments primarily during fiscal 2026.

Fiscal 2024 Restructuring Initiative

During the fourth quarter of fiscal 2024, we commenced an enterprise-wide restructuring initiative intended to align field labor resources with where customers want to shop and to optimize the customer experience, redirect corporate resources for better alignment with our strategy and right-size resources to better align with our revenue outlook for fiscal 2025. We do not expect to incur material future restructuring charges related to this initiative.

All charges incurred related to this initiative were comprised of employee termination benefits from continuing operations and were presented within Restructuring charges on our Condensed Consolidated Statements of Earnings as follows ($ in millions):
Three Months EndedSix Months EndedCumulative Amount as of
August 2, 2025August 3, 2024August 2, 2025August 3, 2024August 2, 2025
Domestic$(2)7$(4)$10$162
International-(1)--8
Total$(2)$6$(4)$10$170
Restructuring accrual activity related to this initiative was as follows ($ in millions):
Termination Benefits
DomesticInternationalTotal
Balances at February 1, 2025$80$5$85
Cash payments(15)(1)(16)
Adjustments(1)
(4)-(4)
Balances at August 2, 2025$61$4$65
(1)Represents adjustments primarily related to higher-than-expected employee retention from previously planned organizational changes.

Our restructuring accrual liabilities related to termination benefits of $65 million as of August 2, 2025, reflect expected future cash payments primarily during fiscal 2026.
v3.25.2
Goodwill and Intangible Assets
 6 Months Ended
Aug. 02, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
Goodwill

Goodwill balances by segment were as follows ($ in millions):
August 2, 2025February 1, 2025August 3, 2024
Gross Carrying AmountCumulative ImpairmentGross Carrying AmountCumulative ImpairmentGross Carrying AmountCumulative Impairment
Domestic$1,450$(542)$1,450$(542)$1,450$(67)
International608(608)608(608)608(608)
Total$2,058$(1,150)$2,058$(1,150)$2,058$(675)
In fiscal 2025, we recorded a goodwill impairment of $475 million within the Domestic segment for the Best Buy Health reporting unit. The restructuring activity that commenced in the first quarter of fiscal 2026 was a triggering event to evaluate the Best Buy Health reporting unit for impairment. No further goodwill impairment was identified. Refer to Note 2, Restructuring, for additional information.

Indefinite-Lived Intangible Assets

In the second quarter of fiscal 2026, we recorded a full impairment of $16 million related to our only remaining indefinite-lived intangible asset as a result of restructuring activity that commenced in the second quarter of fiscal 2026. Refer to Note 2, Restructuring, for additional information.

Definite-Lived Intangible Assets

We have definite-lived intangible assets recorded within Other assets on our Condensed Consolidated Balance Sheets as follows ($ in millions):
August 2, 2025February 1, 2025August 3, 2024Weighted-Average Useful Life Remaining
as of August 2, 2025
(in years)
Gross Carrying
Amount(1)
Accumulated
Amortization(1)
Gross Carrying
Amount		Accumulated
Amortization		Gross Carrying
Amount		Accumulated
Amortization
Customer relationships$339$284$360$285$360$2808.0
Tradenames8778927992751.2
Developed technology565664616460-
Total$482$418$516$425$516$4157.0
(1)Gross carrying amount and accumulated amortization as of August 2, 2025, excludes $34 million and $16 million, respectively, of definite-lived intangible assets related to the exit of a component of our Best Buy Health business. See Note 2, Restructuring, for additional information.

Amortization expense included in Selling, general and administrative expenses ("SG&A") on our Condensed Consolidated Statements of Earnings was as follows ($ in millions):
Three Months EndedSix Months Ended
August 2, 2025August 3, 2024August 2, 2025August 3, 2024
Amortization expense$4 $5 $9$11
Amortization expense expected to be recognized in future periods is as follows ($ in millions):
Amortization Expense
Remainder of fiscal 2026$7
Fiscal 202713
Fiscal 20288
Fiscal 20297
Fiscal 20306
Fiscal 20315
Thereafter18
v3.25.2
Fair Value Measurements
 6 Months Ended
Aug. 02, 2025
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
Fair value measurements are reported in one of three levels based on the lowest level of significant input used: Level 1 (unadjusted quoted prices in active markets); Level 2 (observable market inputs, other than quoted prices included in Level 1); and Level 3 (unobservable inputs that cannot be corroborated by observable market data).

Recurring Fair Value Measurements

Financial assets and liabilities accounted for at fair value were as follows ($ in millions):
Fair Value as of
Balance Sheet Location(1)
Fair Value HierarchyAugust 2, 2025February 1, 2025August 3, 2024
Assets
Money market funds(2)
Cash and cash equivalentsLevel 1$78$439$212
Time deposits(3)
Cash and cash equivalentsLevel 2258150136
Money market funds(2)
Other current assetsLevel 1123140147
Time deposits(3)
Other current assetsLevel 2405051
Marketable securities that fund deferred compensation(4)
Other assetsLevel 1403938
Liabilities
Interest rate swap derivative instruments(5)
Long-term liabilitiesLevel 2-142
(1)Balance sheet location is determined by the length to maturity at date of purchase and whether the assets are restricted for particular use.
(2)Valued at quoted market prices in active markets at period end.
(3)Valued at face value plus accrued interest at period end, which approximates fair value.
(4)Valued using the performance of mutual funds that trade with sufficient frequency and volume to obtain pricing information on an ongoing basis.
(5)Valued using readily observable market inputs. These instruments are custom, over-the-counter contracts with various bank counterparties that are not traded on an active market. See Note 5, Derivative Instruments, for additional information.
Nonrecurring Fair Value Measurements

In the second quarter and first six months of fiscal 2026, we recorded asset impairments and other costs as a result of restructuring initiatives that commenced in the first and second quarters of fiscal 2026. These fair value remeasurements were based on significant unobservable inputs (Level 3). Refer to Note 2, Restructuring, for additional information.

Fair Value of Financial Instruments

The fair values of cash, certain restricted cash, receivables, accounts payable and other payables approximated their carrying values because of the short-term nature of these instruments. If these instruments were measured at fair value in the financial statements, they would be classified as Level 1 in the fair value hierarchy. Fair values for other investments held at cost are not readily available, but we estimate that the carrying values for these investments approximate their fair values.

Long-term debt is presented at carrying value on our Condensed Consolidated Balance Sheets. If our long-term debt were recorded at fair value, it would be classified as Level 2 in the fair value hierarchy. Long-term debt balances were as follows ($ in millions):
August 2, 2025February 1, 2025August 3, 2024
Fair ValueCarrying ValueFair ValueCarrying ValueFair ValueCarrying Value
Long-term debt(1)
$1,077$1,150$1,031$1,136$1,058$1,148
(1)Excludes debt discounts, issuance costs and finance lease obligations.
v3.25.2
Derivative Instruments
 6 Months Ended
Aug. 02, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments Derivative Instruments
We manage our economic and transaction exposure to certain risks by using foreign exchange forward contracts to hedge against the effect of Canadian dollar exchange rate fluctuations on a portion of our net investment in our Canadian operations and by using interest rate swaps to mitigate interest rate risk on our $500 million of principal amount of notes due October 1, 2028. In addition, we use foreign currency forward contracts not designated as hedging instruments to manage the impact of fluctuations in foreign currency exchange rates relative to recognized receivable and payable balances denominated in non-functional currencies.
Our derivative instruments designated as net investment hedges and fair value hedges are recorded on our Condensed Consolidated Balance Sheets at fair value. See Note 4, Fair Value Measurements, for gross fair values of our outstanding derivative instruments and corresponding fair value classifications.

Notional amounts of our derivative instruments were as follows ($ in millions):
Contract TypeAugust 2, 2025February 1, 2025August 3, 2024
Derivatives designated as net investment hedges$119$119$103
Derivatives designated as fair value hedges (interest rate swaps)500500500
No hedge designation (foreign exchange contracts)624259
Total$681$661$662

Effects of our fair value hedges included in Interest expense on our Condensed Consolidated Statements of Earnings were as follows ($ in millions):
Gain (Loss) Recognized
Three Months EndedSix Months Ended
August 2, 2025August 3, 2024August 2, 2025August 3, 2024
Interest rate swaps$9$24$15$9
Adjustments to carrying value of long-term debt(9)(24)(15)(9)
Total$-$-$-$-
v3.25.2
Debt
 6 Months Ended
Aug. 02, 2025
Debt Disclosure [Abstract]  
Debt Debt
Short-Term Debt

U.S. Revolving Credit Facility

On April 18, 2025, we entered into a $1.25 billion five-year senior unsecured revolving credit facility agreement (the “Five-Year Facility Agreement”) with a syndicate of banks. The Five-Year Facility Agreement replaced the previous $1.25 billion senior unsecured revolving credit facility (the “Previous Facility”) with a syndicate of banks, which was entered into April 2023 and scheduled to expire April 2028, but was terminated on April 18, 2025. The Five-Year Facility Agreement permits borrowings of up to $1.25 billion and expires in April 2030. There were no borrowings outstanding under the Five-Year Facility Agreement as of August 2, 2025, or the Previous Facility as of February 1, 2025, or August 3, 2024.

Long-Term Debt

Long-term debt consisted of the following ($ in millions):
August 2, 2025February 1, 2025August 3, 2024
Notes, 4.45%, due October 1, 2028 ("2028 Notes")
$500$500$500
Notes, 1.95%, due October 1, 2030 ("2030 Notes")
650650650
Interest rate swap valuation adjustments-(14)(2)
Subtotal1,1501,1361,148
Debt discounts and issuance costs(6)(7)(7)
Finance lease obligations302529
Total long-term debt1,1741,1541,170
Less current portion101013
Total long-term debt, less current portion$1,164$1,144$1,157

Fair Value and Future Maturities

See Note 4, Fair Value Measurements, for the fair value of long-term debt. Both the 2028 Notes and the 2030 Notes mature within the next five fiscal years.
v3.25.2
Revenue
 6 Months Ended
Aug. 02, 2025
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
We generate substantially all of our revenue from contracts with customers from the sale of products and services. Contract balances primarily relate to unfulfilled membership benefits and services not yet completed, product merchandise not yet delivered to customers, deferred revenue from our private label and co-branded credit card arrangement and unredeemed gift cards. Contract balances were as follows ($ in millions):
August 2, 2025February 1, 2025August 3, 2024
Receivables, net(1)
$486$504$474
Short-term contract liabilities included in:
Unredeemed gift card liabilities230253243
Deferred revenue889951940
Accrued liabilities605064
Long-term contract liabilities included in:
Long-term liabilities213229233
(1)Receivables are recorded net of allowances for expected credit losses of $14 million, $20 million and $16 million as of August 2, 2025, February 1, 2025, and August 3, 2024, respectively.

During the first six months of fiscal 2026 and fiscal 2025, $853 million and $893 million of revenue was recognized, respectively, that was included in the contract liabilities at the beginning of the respective periods.

Estimated revenue from our contract liability balances expected to be recognized in future periods if the performance of the contract is expected to have an initial duration of more than one year is as follows ($ in millions):
Fiscal YearAmount
Remainder of fiscal 2026$17
Fiscal 202733
Fiscal 202829
Fiscal 202926
Fiscal 203026
Fiscal 203126
Thereafter89

See Note 11, Segments, for information on our revenue by reportable segment and product category.
v3.25.2
Earnings per Share
 6 Months Ended
Aug. 02, 2025
Earnings Per Share [Abstract]  
Earnings per Share Earnings per Share
We compute our basic earnings per share based on the weighted-average number of common shares outstanding and our diluted earnings per share based on the weighted-average number of common shares outstanding adjusted by the number of additional shares that would have been outstanding had the potentially dilutive common shares been issued as calculated using the treasury stock method.

Reconciliations of the numerators and denominators of basic and diluted earnings per share were as follows ($ and shares in millions, except per share amounts):
Three Months EndedSix Months Ended
August 2, 2025August 3, 2024August 2, 2025August 3, 2024
Numerator
Net earnings$186$291$388$537
Denominator
Weighted-average common shares outstanding211.5216.0211.8216.1
Dilutive effect of stock compensation plan awards0.51.10.71.1
Weighted-average common shares outstanding, assuming dilution212.0217.1212.5217.2
Potential shares which were anti-dilutive and excluded from weighted-average share computations0.2-0.1-
Basic earnings per share$0.88$1.35$1.83$2.49
Diluted earnings per share$0.87$1.34$1.82$2.47
v3.25.2
Repurchase of Common Stock
 6 Months Ended
Aug. 02, 2025
Equity [Abstract]  
Repurchase of Common Stock Repurchase of Common Stock
On February 28, 2022, our Board of Directors approved a $5.0 billion share repurchase program. The program had $3.1 billion remaining available for repurchases as of August 2, 2025. There is no expiration date governing the period over which we can repurchase shares under this authorization.

Information regarding the shares we repurchased and retired was as follows ($ and shares in millions, except per share amounts):
Three Months EndedSix Months Ended
August 2, 2025August 3, 2024August 2, 2025August 3, 2024
Total cost of shares repurchased$67$98$167$150
Average price per share$68.65$82.57$66.03$80.86
Number of shares repurchased and retired0.91.12.51.8
v3.25.2
Contingencies
 6 Months Ended
Aug. 02, 2025
Commitments and Contingencies Disclosure [Abstract]  
Contingencies Contingencies
We are involved in a number of legal proceedings. Where appropriate, we have made accruals with respect to these matters, which are reflected on our Condensed Consolidated Financial Statements. However, there are cases where liability is not probable or the amount cannot be reasonably estimated and, therefore, accruals have not been made. We provide disclosure of matters where we believe it is reasonably possible the impact may be material to our Condensed Consolidated Financial Statements.
v3.25.2
Segments
 6 Months Ended
Aug. 02, 2025
Segment Reporting [Abstract]  
Segments Segments
Segment and category revenue information was as follows ($ in millions):
Three Months EndedSix Months Ended
August 2, 2025August 3, 2024August 2, 2025August 3, 2024
Domestic:
Computing and Mobile Phones$3,930$3,792$7,722$7,380
Consumer Electronics2,3512,4784,5884,842
Appliances1,0741,1772,0752,267
Entertainment6814981,1301,018
Services5815901,1601,168
Other8188150151
Total Domestic revenue$8,698$8,623$16,825$16,826
International:
Computing and Mobile Phones$346$308$670$626
Consumer Electronics198186371359
Appliances8086137146
Entertainment683911085
Services39387677
Other981616
Total International revenue7406651,3801,309
Total revenue$9,438$9,288$18,205$18,135

Adjusted operating income by segment and the reconciliation to consolidated earnings before income tax expense and equity in income of affiliates were as follows ($ in millions):
Three Months Ended
August 2, 2025August 3, 2024
Domestic (1)
InternationalTotal
Domestic (1)
InternationalTotal
Revenue$8,698$740$9,438$8,623$665$9,288
Cost of sales6,6655797,2446,5965067,102
Adjusted SG&A (2)
1,6821431,8251,6631421,805
Adjusted operating income$351$18369$364$17381
Restructuring charges114(7)
Intangible asset amortization45
Operating income251383
Other income (expense):
Loss on disposal of subsidiaries(4)-
Investment income and other1821
Interest expense(12)(13)
Earnings before income tax expense and equity in income of affiliates$253$391
(1)Domestic segment adjusted operating income includes certain operations that are based in foreign tax jurisdictions and primarily relate to sourcing products into the U.S.
(2)Adjusted SG&A excludes amortization of definite-lived intangible assets associated with acquisitions.
Six Months Ended
August 2, 2025August 3, 2024
Domestic (1)
InternationalTotal
Domestic (1)
InternationalTotal
Revenue$16,825$1,380$18,205$16,826$1,309$18,135
Cost of sales12,8841,07813,96212,8821,00313,885
Adjusted SG&A (2)
3,2612803,5413,2552813,536
Adjusted operating income$680$22702$689$25714
Restructuring charges2238
Intangible asset amortization911
Operating income470695
Other income (expense):
Loss on disposal of subsidiaries(4)-
Investment income and other3346
Interest expense(24)(25)
Earnings before income tax expense and equity in income of affiliates$475$716
(1)Domestic segment adjusted operating income includes certain operations that are based in foreign tax jurisdictions and primarily relate to sourcing products into the U.S.
(2)Adjusted SG&A excludes amortization of definite-lived intangible assets associated with acquisitions.

Other expense and cash flow information by segment was as follows ($ in millions):
Three Months EndedSix Months Ended
August 2, 2025August 3, 2024August 2, 2025August 3, 2024
Capital expenditures
Domestic$161$160$311$298
International14233037
Total capital expenditures$175$183$341$335
Depreciation and amortization
Domestic$201$208$402$417
International10102020
Total depreciation and amortization$211$218$422$437

Asset information by segment was as follows ($ in millions):
August 2, 2025February 1, 2025August 3, 2024
Domestic$13,926 $13,567 $14,471 
International1,327 1,215 1,153 
Total assets$15,253 $14,782 $15,624 
v3.25.2
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Aug. 02, 2025
Aug. 03, 2024
Pay vs Performance Disclosure        
Net earnings $ 186 $ 291 $ 388 $ 537
v3.25.2
Insider Trading Arrangements
 3 Months Ended
Aug. 02, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.2
Organization, Consolidation and Presentation of Financial Statements (Policies)
 6 Months Ended
Aug. 02, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Recently Issued Accounting Pronouncements and Recently Enabled Tax Legislation
Recently Issued Accounting Pronouncements

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires disclosure of specific categories meeting a quantitative threshold within the income tax rate reconciliation, as well as disaggregation of income taxes paid by jurisdiction. This ASU, which can be applied either prospectively or retrospectively, is effective for annual periods beginning after December 15, 2024, with early adoption permitted. We are currently evaluating the impact of the ASU and expect to include updated income tax disclosures in our fiscal 2026 Form 10-K.

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure of specific expense categories in the notes to financial statements. The amendments are effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. We are currently evaluating the impact of the ASU and expect to include updated expense disclosures in our fiscal 2028 Form 10-K.

Recently Enacted Tax Legislation

On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (“OB3”). The OB3 extends key provisions of the 2017 Tax Cuts and Jobs Act, including, but not limited to, domestic research expensing, 100% bonus depreciation on tangible property and modifications to the international tax framework. The provisions will not have a material impact on our income tax expense.
v3.25.2
Basis of Presentation (Tables)
 6 Months Ended
Aug. 02, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Total Cash, Cash Equivalents and Restricted Cash
Cash, cash equivalents and restricted cash reported on our Condensed Consolidated Balance Sheets are reconciled to the totals shown on our Condensed Consolidated Statements of Cash Flows as follows ($ in millions):
August 2, 2025February 1, 2025August 3, 2024
Cash and cash equivalents$1,456$1,578$1,387
Restricted cash included in Other current assets257290311
Total cash, cash equivalents and restricted cash$1,713$1,868$1,698
v3.25.2
Restructuring (Tables)
 6 Months Ended
Aug. 02, 2025
Restructuring and Related Activities [Abstract]  
Schedule of Composition of Restructuring Charges
Restructuring charges were as follows ($ in millions):
Three Months EndedSix Months Ended
August 2, 2025August 3, 2024August 2, 2025August 3, 2024
Fiscal 2026 Labor and Store Optimization Initiative$122$-$122$-
Best Buy Health Optimization and China Sourcing Initiative(6)-105-
Fiscal 2024 Restructuring Initiative(2)(6)(4)10
Fiscal 2023 Resource Optimization Initiative-(1)-(2)
Total$114$(7)$223$8
The composition of restructuring charges incurred related to this initiative were as follows ($ in millions):
Three Months Ended
DomesticInternationalTotal
Termination benefits$78$3$81
Asset impairments(1)
41-41
Total$119$3$122
(1)Represents asset impairments primarily related to planned store closures, including an impairment related to an indefinite-lived tradename. See Note 3, Goodwill and Intangible Assets, for additional information. The remaining carrying value of net assets approximates fair value and was immaterial as of August 2, 2025.
The composition of restructuring charges incurred related to this initiative were as follows ($ in millions):
Three Months EndedSix Months Ended
August 2, 2025August 2, 2025
Asset impairments and other costs(1)
$(3)$70
Termination benefits(3)35
Total$(6)$105
(1)Primarily represents the full impairment of net assets related to a component of our Best Buy Health business and other exit costs. The remaining carrying value of net assets approximates fair value and was immaterial as of August 2, 2025.
All charges incurred related to this initiative were comprised of employee termination benefits from continuing operations and were presented within Restructuring charges on our Condensed Consolidated Statements of Earnings as follows ($ in millions):
Three Months EndedSix Months EndedCumulative Amount as of
August 2, 2025August 3, 2024August 2, 2025August 3, 2024August 2, 2025
Domestic$(2)7$(4)$10$162
International-(1)--8
Total$(2)$6$(4)$10$170
Schedule of Restructuring Accrual Activity
Restructuring accrual activity related to this initiative was as follows ($ in millions):
Termination BenefitsAsset Impairments and Other CostsTotal
Balances at February 1, 2025$-$-$-
Charges382866
Cash payments(9)(27)(36)
Adjustments(1)
(3)(1)(4)
Balances at August 2, 2025$26$-$26
(1)Primarily represents adjustments for termination benefits primarily related to higher-than-expected employee retention from previously planned organizational changes.
Restructuring accrual activity related to this initiative was as follows ($ in millions):
Termination Benefits
DomesticInternationalTotal
Balances at February 1, 2025$80$5$85
Cash payments(15)(1)(16)
Adjustments(1)
(4)-(4)
Balances at August 2, 2025$61$4$65
(1)Represents adjustments primarily related to higher-than-expected employee retention from previously planned organizational changes.
v3.25.2
Goodwill and Intangible Assets (Tables)
 6 Months Ended
Aug. 02, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
Goodwill balances by segment were as follows ($ in millions):
August 2, 2025February 1, 2025August 3, 2024
Gross Carrying AmountCumulative ImpairmentGross Carrying AmountCumulative ImpairmentGross Carrying AmountCumulative Impairment
Domestic$1,450$(542)$1,450$(542)$1,450$(67)
International608(608)608(608)608(608)
Total$2,058$(1,150)$2,058$(1,150)$2,058$(675)
Schedule of Definite-Lived Intangible Assets
We have definite-lived intangible assets recorded within Other assets on our Condensed Consolidated Balance Sheets as follows ($ in millions):
August 2, 2025February 1, 2025August 3, 2024Weighted-Average Useful Life Remaining
as of August 2, 2025
(in years)
Gross Carrying
Amount(1)
Accumulated
Amortization(1)
Gross Carrying
Amount		Accumulated
Amortization		Gross Carrying
Amount		Accumulated
Amortization
Customer relationships$339$284$360$285$360$2808.0
Tradenames8778927992751.2
Developed technology565664616460-
Total$482$418$516$425$516$4157.0
(1)Gross carrying amount and accumulated amortization as of August 2, 2025, excludes $34 million and $16 million, respectively, of definite-lived intangible assets related to the exit of a component of our Best Buy Health business. See Note 2, Restructuring, for additional information.
Schedule of Amortization Expense
Amortization expense included in Selling, general and administrative expenses ("SG&A") on our Condensed Consolidated Statements of Earnings was as follows ($ in millions):
Three Months EndedSix Months Ended
August 2, 2025August 3, 2024August 2, 2025August 3, 2024
Amortization expense$4 $5 $9$11
Schedule of Amortization Expense Expected to be Recognized
Amortization expense expected to be recognized in future periods is as follows ($ in millions):
Amortization Expense
Remainder of fiscal 2026$7
Fiscal 202713
Fiscal 20288
Fiscal 20297
Fiscal 20306
Fiscal 20315
Thereafter18
v3.25.2
Fair Value Measurements (Tables)
 6 Months Ended
Aug. 02, 2025
Fair Value Disclosures [Abstract]  
Schedule of Financial assets and liabilities
Financial assets and liabilities accounted for at fair value were as follows ($ in millions):
Fair Value as of
Balance Sheet Location(1)
Fair Value HierarchyAugust 2, 2025February 1, 2025August 3, 2024
Assets
Money market funds(2)
Cash and cash equivalentsLevel 1$78$439$212
Time deposits(3)
Cash and cash equivalentsLevel 2258150136
Money market funds(2)
Other current assetsLevel 1123140147
Time deposits(3)
Other current assetsLevel 2405051
Marketable securities that fund deferred compensation(4)
Other assetsLevel 1403938
Liabilities
Interest rate swap derivative instruments(5)
Long-term liabilitiesLevel 2-142
(1)Balance sheet location is determined by the length to maturity at date of purchase and whether the assets are restricted for particular use.
(2)Valued at quoted market prices in active markets at period end.
(3)Valued at face value plus accrued interest at period end, which approximates fair value.
(4)Valued using the performance of mutual funds that trade with sufficient frequency and volume to obtain pricing information on an ongoing basis.
(5)Valued using readily observable market inputs. These instruments are custom, over-the-counter contracts with various bank counterparties that are not traded on an active market. See Note 5, Derivative Instruments, for additional information.
Schedule of Fair Value of Financial Instruments Long-term debt balances were as follows ($ in millions):
August 2, 2025February 1, 2025August 3, 2024
Fair ValueCarrying ValueFair ValueCarrying ValueFair ValueCarrying Value
Long-term debt(1)
$1,077$1,150$1,031$1,136$1,058$1,148
(1)Excludes debt discounts, issuance costs and finance lease obligations.
v3.25.2
Derivative Instruments (Tables)
 6 Months Ended
Aug. 02, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Notional Amount of Derivative Instruments
Notional amounts of our derivative instruments were as follows ($ in millions):
Contract TypeAugust 2, 2025February 1, 2025August 3, 2024
Derivatives designated as net investment hedges$119$119$103
Derivatives designated as fair value hedges (interest rate swaps)500500500
No hedge designation (foreign exchange contracts)624259
Total$681$661$662
Schedule of Effects of Derivative Instruments on Consolidated Statements of Earnings
Effects of our fair value hedges included in Interest expense on our Condensed Consolidated Statements of Earnings were as follows ($ in millions):
Gain (Loss) Recognized
Three Months EndedSix Months Ended
August 2, 2025August 3, 2024August 2, 2025August 3, 2024
Interest rate swaps$9$24$15$9
Adjustments to carrying value of long-term debt(9)(24)(15)(9)
Total$-$-$-$-
v3.25.2
Debt (Tables)
 6 Months Ended
Aug. 02, 2025
Debt Disclosure [Abstract]  
Schedule of Long-term Debt
Long-term debt consisted of the following ($ in millions):
August 2, 2025February 1, 2025August 3, 2024
Notes, 4.45%, due October 1, 2028 ("2028 Notes")
$500$500$500
Notes, 1.95%, due October 1, 2030 ("2030 Notes")
650650650
Interest rate swap valuation adjustments-(14)(2)
Subtotal1,1501,1361,148
Debt discounts and issuance costs(6)(7)(7)
Finance lease obligations302529
Total long-term debt1,1741,1541,170
Less current portion101013
Total long-term debt, less current portion$1,164$1,144$1,157
v3.25.2
Revenue (Tables)
 6 Months Ended
Aug. 02, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Contract Balances and Changes in Contract Balances Contract balances primarily relate to unfulfilled membership benefits and services not yet completed, product merchandise not yet delivered to customers, deferred revenue from our private label and co-branded credit card arrangement and unredeemed gift cards. Contract balances were as follows ($ in millions):
August 2, 2025February 1, 2025August 3, 2024
Receivables, net(1)
$486$504$474
Short-term contract liabilities included in:
Unredeemed gift card liabilities230253243
Deferred revenue889951940
Accrued liabilities605064
Long-term contract liabilities included in:
Long-term liabilities213229233
(1)Receivables are recorded net of allowances for expected credit losses of $14 million, $20 million and $16 million as of August 2, 2025, February 1, 2025, and August 3, 2024, respectively.
Schedule of Expected Timing for Satisfying Remaining Performance Obligation
Estimated revenue from our contract liability balances expected to be recognized in future periods if the performance of the contract is expected to have an initial duration of more than one year is as follows ($ in millions):
Fiscal YearAmount
Remainder of fiscal 2026$17
Fiscal 202733
Fiscal 202829
Fiscal 202926
Fiscal 203026
Fiscal 203126
Thereafter89
v3.25.2
Earnings per Share (Tables)
 6 Months Ended
Aug. 02, 2025
Earnings Per Share [Abstract]  
Schedule of Calculation of Numerator and Denominator in Earnings Per Share
Reconciliations of the numerators and denominators of basic and diluted earnings per share were as follows ($ and shares in millions, except per share amounts):
Three Months EndedSix Months Ended
August 2, 2025August 3, 2024August 2, 2025August 3, 2024
Numerator
Net earnings$186$291$388$537
Denominator
Weighted-average common shares outstanding211.5216.0211.8216.1
Dilutive effect of stock compensation plan awards0.51.10.71.1
Weighted-average common shares outstanding, assuming dilution212.0217.1212.5217.2
Potential shares which were anti-dilutive and excluded from weighted-average share computations0.2-0.1-
Basic earnings per share$0.88$1.35$1.83$2.49
Diluted earnings per share$0.87$1.34$1.82$2.47
v3.25.2
Repurchase of Common Stock (Tables)
 6 Months Ended
Aug. 02, 2025
Equity [Abstract]  
Schedule of Share Repurchases and Retired
Information regarding the shares we repurchased and retired was as follows ($ and shares in millions, except per share amounts):
Three Months EndedSix Months Ended
August 2, 2025August 3, 2024August 2, 2025August 3, 2024
Total cost of shares repurchased$67$98$167$150
Average price per share$68.65$82.57$66.03$80.86
Number of shares repurchased and retired0.91.12.51.8
v3.25.2
Segments (Tables)
 6 Months Ended
Aug. 02, 2025
Segment Reporting [Abstract]  
Schedule of Revenue by Reportable Segment and Product Category
Segment and category revenue information was as follows ($ in millions):
Three Months EndedSix Months Ended
August 2, 2025August 3, 2024August 2, 2025August 3, 2024
Domestic:
Computing and Mobile Phones$3,930$3,792$7,722$7,380
Consumer Electronics2,3512,4784,5884,842
Appliances1,0741,1772,0752,267
Entertainment6814981,1301,018
Services5815901,1601,168
Other8188150151
Total Domestic revenue$8,698$8,623$16,825$16,826
International:
Computing and Mobile Phones$346$308$670$626
Consumer Electronics198186371359
Appliances8086137146
Entertainment683911085
Services39387677
Other981616
Total International revenue7406651,3801,309
Total revenue$9,438$9,288$18,205$18,135
Schedule of Operating Income by Reportable Segment and Reconciliation to Earnings Before Income Tax Expense
Adjusted operating income by segment and the reconciliation to consolidated earnings before income tax expense and equity in income of affiliates were as follows ($ in millions):
Three Months Ended
August 2, 2025August 3, 2024
Domestic (1)
InternationalTotal
Domestic (1)
InternationalTotal
Revenue$8,698$740$9,438$8,623$665$9,288
Cost of sales6,6655797,2446,5965067,102
Adjusted SG&A (2)
1,6821431,8251,6631421,805
Adjusted operating income$351$18369$364$17381
Restructuring charges114(7)
Intangible asset amortization45
Operating income251383
Other income (expense):
Loss on disposal of subsidiaries(4)-
Investment income and other1821
Interest expense(12)(13)
Earnings before income tax expense and equity in income of affiliates$253$391
(1)Domestic segment adjusted operating income includes certain operations that are based in foreign tax jurisdictions and primarily relate to sourcing products into the U.S.
(2)Adjusted SG&A excludes amortization of definite-lived intangible assets associated with acquisitions.
Six Months Ended
August 2, 2025August 3, 2024
Domestic (1)
InternationalTotal
Domestic (1)
InternationalTotal
Revenue$16,825$1,380$18,205$16,826$1,309$18,135
Cost of sales12,8841,07813,96212,8821,00313,885
Adjusted SG&A (2)
3,2612803,5413,2552813,536
Adjusted operating income$680$22702$689$25714
Restructuring charges2238
Intangible asset amortization911
Operating income470695
Other income (expense):
Loss on disposal of subsidiaries(4)-
Investment income and other3346
Interest expense(24)(25)
Earnings before income tax expense and equity in income of affiliates$475$716
(1)Domestic segment adjusted operating income includes certain operations that are based in foreign tax jurisdictions and primarily relate to sourcing products into the U.S.
(2)Adjusted SG&A excludes amortization of definite-lived intangible assets associated with acquisitions.
Schedule of Other Information by Segment Information
Other expense and cash flow information by segment was as follows ($ in millions):
Three Months EndedSix Months Ended
August 2, 2025August 3, 2024August 2, 2025August 3, 2024
Capital expenditures
Domestic$161$160$311$298
International14233037
Total capital expenditures$175$183$341$335
Depreciation and amortization
Domestic$201$208$402$417
International10102020
Total depreciation and amortization$211$218$422$437

Asset information by segment was as follows ($ in millions):
August 2, 2025February 1, 2025August 3, 2024
Domestic$13,926 $13,567 $14,471 
International1,327 1,215 1,153 
Total assets$15,253 $14,782 $15,624 
v3.25.2
Basis of Presentation (Narrative) (Details) - USD ($)
$ in Millions
Aug. 02, 2025
Feb. 01, 2025
Aug. 03, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Liability associated with funded participation $ 872 $ 398 $ 729
v3.25.2
Basis of Presentation (Schedule of Total Cash, Cash Equivalents and Restricted Cash) (Details) - USD ($)
$ in Millions
Aug. 02, 2025
Feb. 01, 2025
Aug. 03, 2024
Feb. 03, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Cash and cash equivalents $ 1,456 $ 1,578 [1] $ 1,387  
Restricted cash included in Other current assets 257 290 311  
Total cash, cash equivalents and restricted cash $ 1,713 $ 1,868 $ 1,698 $ 1,793
[1] The Consolidated Balance Sheet as of February 1, 2025, has been condensed from the audited consolidated financial statements.
v3.25.2
Restructuring (Schedule of Restructuring Charges) (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Aug. 02, 2025
Aug. 03, 2024
Restructuring Cost and Reserve [Line Items]        
Restructuring charges $ 114 $ (7) $ 223 $ 8
Fiscal 2026 Labor and Store Optimization Initiative        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 122 0 122 0
Best Buy Health Optimization and China Sourcing Initiative        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (6) 0 105 0
Fiscal 2024 Restructuring Initiative        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (2) (6) (4) 10
Fiscal 2023 Resource Optimization Initiative        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges $ 0 $ (1) $ 0 $ (2)
v3.25.2
Restructuring (Schedule of Composition of Restructuring Charges) (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Aug. 02, 2025
Aug. 03, 2024
Restructuring Cost and Reserve [Line Items]        
Restructuring charges $ 114 $ (7) $ 223 $ 8
Fiscal 2026 Labor and Store Optimization Initiative        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 122 0 122 0
Fiscal 2026 Labor and Store Optimization Initiative | Domestic        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 119      
Fiscal 2026 Labor and Store Optimization Initiative | International        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 3      
Best Buy Health Optimization and China Sourcing Initiative        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (6) $ 0 105 $ 0
Termination benefits | Fiscal 2026 Labor and Store Optimization Initiative        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 81      
Termination benefits | Fiscal 2026 Labor and Store Optimization Initiative | Domestic        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 78      
Termination benefits | Fiscal 2026 Labor and Store Optimization Initiative | International        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 3      
Termination benefits | Best Buy Health Optimization and China Sourcing Initiative        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (3)   35  
Asset impairments | Fiscal 2026 Labor and Store Optimization Initiative        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 41      
Asset impairments | Fiscal 2026 Labor and Store Optimization Initiative | Domestic        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 41      
Asset impairments | Fiscal 2026 Labor and Store Optimization Initiative | International        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 0      
Asset Impairments and Other Costs | Best Buy Health Optimization and China Sourcing Initiative        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges $ (3)   $ 70  
v3.25.2
Restructuring (Narrative) (Details) - USD ($)
$ in Millions
Aug. 02, 2025
Feb. 01, 2025
Fiscal 2026 Labor and Store Optimization Initiative    
Restructuring Cost and Reserve [Line Items]    
Restructuring reserve $ 81  
Fiscal 2024 Restructuring Initiative | Termination benefits    
Restructuring Cost and Reserve [Line Items]    
Restructuring reserve $ 65 $ 85
v3.25.2
Restructuring (Schedule of Restructuring Initiative ) (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Aug. 02, 2025
Aug. 03, 2024
Restructuring Cost and Reserve [Line Items]        
Restructuring charges $ 114 $ (7) $ 223 $ 8
Fiscal 2024 Restructuring Initiative        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (2) (6) (4) 10
Termination benefits | Fiscal 2024 Restructuring Initiative        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (2) 6 (4) 10
Cumulative Amount as of 170   170  
Termination benefits | Fiscal 2024 Restructuring Initiative | Domestic        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (2) 7 (4) 10
Cumulative Amount as of 162   162  
Termination benefits | Fiscal 2024 Restructuring Initiative | International        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 0 $ (1) 0 $ 0
Cumulative Amount as of $ 8   $ 8  
v3.25.2
Restructuring (Schedule of Restructuring Accrual Activity) (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Aug. 02, 2025
Aug. 03, 2024
Restructuring Reserve [Roll Forward]        
Charges $ 114 $ (7) $ 223 $ 8
Best Buy Health Optimization and China Sourcing Initiative        
Restructuring Reserve [Roll Forward]        
Balances     0  
Charges     66  
Cash payments     (36)  
Adjustments     (4)  
Balances 26   26  
Best Buy Health Optimization and China Sourcing Initiative | Termination benefits        
Restructuring Reserve [Roll Forward]        
Balances     0  
Charges     38  
Cash payments     (9)  
Adjustments     (3)  
Balances 26   26  
Best Buy Health Optimization and China Sourcing Initiative | Asset Impairments and Other Costs        
Restructuring Reserve [Roll Forward]        
Balances     0  
Charges     28  
Cash payments     (27)  
Adjustments     (1)  
Balances 0   0  
Fiscal 2024 Restructuring Initiative | Termination benefits        
Restructuring Reserve [Roll Forward]        
Balances     85  
Cash payments     (16)  
Adjustments     (4)  
Balances 65   65  
Domestic | Fiscal 2024 Restructuring Initiative | Termination benefits        
Restructuring Reserve [Roll Forward]        
Balances     80  
Cash payments     (15)  
Adjustments     (4)  
Balances 61   61  
International | Fiscal 2024 Restructuring Initiative | Termination benefits        
Restructuring Reserve [Roll Forward]        
Balances     5  
Cash payments     (1)  
Adjustments     0  
Balances $ 4   $ 4  
v3.25.2
Goodwill and Intangible Assets (Schedule of Goodwill) (Details) - USD ($)
$ in Millions
Aug. 02, 2025
Feb. 01, 2025
Aug. 03, 2024
Goodwill [Line Items]      
Gross Carrying Amount $ 2,058 $ 2,058 $ 2,058
Cumulative Impairment (1,150) (1,150) (675)
Domestic      
Goodwill [Line Items]      
Gross Carrying Amount 1,450 1,450 1,450
Cumulative Impairment (542) (542) (67)
International      
Goodwill [Line Items]      
Gross Carrying Amount 608 608 608
Cumulative Impairment $ (608) $ (608) $ (608)
v3.25.2
Goodwill and Intangible Assets (Narrative) (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Aug. 02, 2025
Feb. 01, 2025
Intangible Assets [Line Items]    
Impairment $ 16  
Domestic    
Intangible Assets [Line Items]    
Goodwill and intangible assets impairment charges   $ 475
v3.25.2
Goodwill and Intangible Assets (Schedule of Definite-Lived Intangible Assets) (Details) - USD ($)
$ in Millions
Aug. 02, 2025
Feb. 01, 2025
Aug. 03, 2024
Acquired Finite-Lived Intangible Assets [Line Items]      
Gross Carrying ‎Amount $ 482 $ 516 $ 516
Accumulated ‎Amortization $ 418 425 415
Weighted-Average Useful Life Remaining ‎ 7 years    
Best Buy Health Optimization and China Sourcing Initiative      
Acquired Finite-Lived Intangible Assets [Line Items]      
Gross Carrying ‎Amount $ 34    
Accumulated ‎Amortization 16    
Customer relationships      
Acquired Finite-Lived Intangible Assets [Line Items]      
Gross Carrying ‎Amount 339 360 360
Accumulated ‎Amortization $ 284 285 280
Weighted-Average Useful Life Remaining ‎ 8 years    
Tradenames      
Acquired Finite-Lived Intangible Assets [Line Items]      
Gross Carrying ‎Amount $ 87 92 92
Accumulated ‎Amortization $ 78 79 75
Weighted-Average Useful Life Remaining ‎ 1 year 2 months 12 days    
Developed technology      
Acquired Finite-Lived Intangible Assets [Line Items]      
Gross Carrying ‎Amount $ 56 64 64
Accumulated ‎Amortization $ 56 $ 61 $ 60
v3.25.2
Goodwill and Intangible Assets (Schedule of Amortization Expense) (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Aug. 02, 2025
Aug. 03, 2024
Goodwill and Intangible Assets Disclosure [Abstract]        
Amortization expense $ 4 $ 5 $ 9 $ 11
v3.25.2
Goodwill and Intangible Assets (Schedule of Amortization Expense Expected to be Recognized) (Details)
$ in Millions
Aug. 02, 2025
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
Remainder of fiscal 2026 $ 7
Fiscal 2027 13
Fiscal 2028 8
Fiscal 2029 7
Fiscal 2030 6
Fiscal 2031 5
Thereafter $ 18
v3.25.2
Fair Value Measurements (Schedule of Financial Assets and Liabilities) (Details) - Fair Value, Measurements, Recurring - USD ($)
$ in Millions
Aug. 02, 2025
Feb. 01, 2025
Aug. 03, 2024
Level 1 | Money market funds      
Assets      
Cash and cash equivalents $ 78 $ 439 $ 212
Other current assets 123 140 147
Level 1 | Marketable securities that fund deferred compensation      
Assets      
Other assets 40 39 38
Level 2 | Time deposits      
Assets      
Cash and cash equivalents 258 150 136
Other current assets 40 50 51
Level 2 | Derivatives designated as fair value hedges (interest rate swaps)      
Liabilities      
Long-term liabilities $ 0 $ 14 $ 2
v3.25.2
Fair Value Measurements (Schedule of Fair Value of Financial Instruments) (Details) - Level 2 - Long-term debt - USD ($)
$ in Millions
Aug. 02, 2025
Feb. 01, 2025
Aug. 03, 2024
Fair Value      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Fair Value $ 1,077 $ 1,031 $ 1,058
Carrying Value      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Fair Value $ 1,150 $ 1,136 $ 1,148
v3.25.2
Derivative Instruments (Narrative) (Details)
$ in Millions
Aug. 02, 2025
USD ($)
Notes Due 2028  
Derivative [Line Items]  
Principal amount of notes $ 500
v3.25.2
Derivative Instruments (Schedule of Notional Amount of Derivative Instruments) (Details) - USD ($)
$ in Millions
Aug. 02, 2025
Feb. 01, 2025
Aug. 03, 2024
Derivatives, Fair Value [Line Items]      
Notional amount $ 681 $ 661 $ 662
Derivatives designated as net investment hedges | Designated As Hedging Instrument      
Derivatives, Fair Value [Line Items]      
Notional amount 119 119 103
Derivatives designated as fair value hedges (interest rate swaps) | Designated As Hedging Instrument      
Derivatives, Fair Value [Line Items]      
Notional amount 500 500 500
No hedge designation (foreign exchange contracts) | Not Designated As Hedging Instrument      
Derivatives, Fair Value [Line Items]      
Notional amount $ 62 $ 42 $ 59
v3.25.2
Derivative Instruments (Schedule of Effects of Derivative Instruments on Consolidated Statements of Earnings) (Details) - Designated As Hedging Instrument - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Aug. 02, 2025
Aug. 03, 2024
Derivatives, Fair Value [Line Items]        
Gain (Loss) Recognized $ 0 $ 0 $ 0 $ 0
Interest rate swaps        
Derivatives, Fair Value [Line Items]        
Gain (Loss) Recognized 9 24 15 9
Adjustments to carrying value of long-term debt        
Derivatives, Fair Value [Line Items]        
Gain (Loss) Recognized $ (9) $ (24) $ (15) $ (9)
v3.25.2
Debt (Narrative) (Details) - Revolving Credit Facility - USD ($)
Apr. 18, 2025
Aug. 02, 2025
Feb. 01, 2025
Aug. 03, 2024
Apr. 30, 2023
Five-Year Facility Agreement          
Line of Credit Facility [Line Items]          
Line of credit facility, maximum borrowing capacity $ 1,250,000,000        
Debt instrument, term 5 years        
Outstanding borrowings   $ 0      
Previous Facility          
Line of Credit Facility [Line Items]          
Line of credit facility, maximum borrowing capacity         $ 1,250,000,000
Outstanding borrowings     $ 0 $ 0  
v3.25.2
Debt (Schedule of Long-Term Debt) (Details) - USD ($)
$ in Millions
Aug. 02, 2025
Feb. 01, 2025
Aug. 03, 2024
Debt Instrument [Line Items]      
Interest rate swap valuation adjustments $ 0 $ (14) $ (2)
Subtotal 1,150 1,136 1,148
Debt discounts and issuance costs (6) (7) (7)
Finance lease obligations 30 25 29
Total long-term debt 1,174 1,154 1,170
Less current portion 10 10 [1] 13
Total long-term debt, less current portion 1,164 1,144 [1] 1,157
Notes Due 2028      
Debt Instrument [Line Items]      
Long-term debt $ 500 500 500
Interest rate 4.45%    
Notes Due 2030      
Debt Instrument [Line Items]      
Long-term debt $ 650 $ 650 $ 650
Interest rate 1.95%    
[1] The Consolidated Balance Sheet as of February 1, 2025, has been condensed from the audited consolidated financial statements.
v3.25.2
Revenue (Schedule of Contract Balances and Changes in Contract Balances) (Details) - USD ($)
$ in Millions
Aug. 02, 2025
Feb. 01, 2025
Aug. 03, 2024
Revenue from Contract with Customer [Line Items]      
Receivables, net $ 486 $ 504 $ 474
Allowance for expected credit loss 14 20 16
Unredeemed gift card liabilities      
Revenue from Contract with Customer [Line Items]      
Short-term contract liabilities included in: 230 253 243
Deferred revenue      
Revenue from Contract with Customer [Line Items]      
Short-term contract liabilities included in: 889 951 [1] 940
Accrued liabilities      
Revenue from Contract with Customer [Line Items]      
Short-term contract liabilities included in: 60 50 64
Long-term liabilities      
Revenue from Contract with Customer [Line Items]      
Long-term liabilities $ 213 $ 229 $ 233
[1] The Consolidated Balance Sheet as of February 1, 2025, has been condensed from the audited consolidated financial statements.
v3.25.2
Revenue (Narrative) (Details) - USD ($)
$ in Millions
 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Revenue from Contract with Customer [Abstract]    
Revenue recognized $ 853 $ 893
v3.25.2
Revenue (Schedule of Expected Timing for Satisfying Remaining Performance Obligation) (Details)
$ in Millions
Aug. 02, 2025
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-08-03  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Estimated revenue from our contract liability balances $ 17
Performance obligations from contract liability balances, duration 6 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-02-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Estimated revenue from our contract liability balances $ 33
Performance obligations from contract liability balances, duration 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-31  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Estimated revenue from our contract liability balances $ 29
Performance obligations from contract liability balances, duration 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-28  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Estimated revenue from our contract liability balances $ 26
Performance obligations from contract liability balances, duration 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2029-02-03  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Estimated revenue from our contract liability balances $ 26
Performance obligations from contract liability balances, duration 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2030-02-02  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Estimated revenue from our contract liability balances $ 26
Performance obligations from contract liability balances, duration 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2031-02-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Estimated revenue from our contract liability balances $ 89
Performance obligations from contract liability balances, duration
v3.25.2
Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Aug. 02, 2025
Aug. 03, 2024
Numerator        
Net earnings $ 186 $ 291 $ 388 $ 537
Denominator        
Weighted-average common shares outstanding (in shares) 211.5 216.0 211.8 216.1
Dilutive effect of stock compensation plan awards (in shares) 0.5 1.1 0.7 1.1
Weighted-average common shares outstanding, assuming dilution (in shares) 212.0 217.1 212.5 217.2
Potential shares which were anti-dilutive and excluded from weighted-average share computations (in shares) 0.2 0.0 0.1 0.0
Basic earnings per share (in dollars per share) $ 0.88 $ 1.35 $ 1.83 $ 2.49
Diluted earnings per share (in dollars per share) $ 0.87 $ 1.34 $ 1.82 $ 2.47
v3.25.2
Repurchase of Common Stock (Narrative) (Details) - USD ($)
$ in Billions
Aug. 02, 2025
Feb. 28, 2022
Equity [Abstract]    
Stock repurchase program, authorized amount   $ 5.0
Remaining authorized repurchase amount $ 3.1  
v3.25.2
Repurchase of Common Stock (Schedule of Share Repurchases) (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Aug. 02, 2025
Aug. 03, 2024
Equity [Abstract]        
Total cost of shares repurchased $ 67 $ 98 $ 167 $ 150
Average price per share $ 68.65 $ 82.57 $ 66.03 $ 80.86
Number of shares repurchased and retired 0.9 1.1 2.5 1.8
v3.25.2
Segments (Schedule of Revenue by Reportable Segment and Product Category) (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Aug. 02, 2025
Aug. 03, 2024
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenue $ 9,438 $ 9,288 $ 18,205 $ 18,135
Domestic        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenue 8,698 8,623 16,825 16,826
Domestic | Computing and Mobile Phones        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenue 3,930 3,792 7,722 7,380
Domestic | Consumer Electronics        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenue 2,351 2,478 4,588 4,842
Domestic | Appliances        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenue 1,074 1,177 2,075 2,267
Domestic | Entertainment        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenue 681 498 1,130 1,018
Domestic | Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenue 581 590 1,160 1,168
Domestic | Other        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenue 81 88 150 151
International        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenue 740 665 1,380 1,309
International | Computing and Mobile Phones        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenue 346 308 670 626
International | Consumer Electronics        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenue 198 186 371 359
International | Appliances        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenue 80 86 137 146
International | Entertainment        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenue 68 39 110 85
International | Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenue 39 38 76 77
International | Other        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenue $ 9 $ 8 $ 16 $ 16
v3.25.2
Segments (Schedule of Operating Income by Reportable Segment and Reconciliation to Earnings Before Income Tax Expense) (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Aug. 02, 2025
Aug. 03, 2024
Business segment information        
Revenue $ 9,438 $ 9,288 $ 18,205 $ 18,135
Cost of sales 7,244 7,102 13,962 13,885
Adjusted SG&A 1,825 1,805 3,541 3,536
Adjusted operating income 369 381 702 714
Restructuring charges 114 (7) 223 8
Intangible asset amortization 4 5 9 11
Operating income 251 383 470 695
Other income (expense):        
Loss on disposal of subsidiaries (4) 0 (4) 0
Investment income and other 18 21 33 46
Interest expense (12) (13) (24) (25)
Earnings before income tax expense and equity in income of affiliates 253 391 475 716
Domestic        
Business segment information        
Revenue 8,698 8,623 16,825 16,826
Cost of sales 6,665 6,596 12,884 12,882
Adjusted SG&A 1,682 1,663 3,261 3,255
Adjusted operating income 351 364 680 689
International        
Business segment information        
Revenue 740 665 1,380 1,309
Cost of sales 579 506 1,078 1,003
Adjusted SG&A 143 142 280 281
Adjusted operating income $ 18 $ 17 $ 22 $ 25
v3.25.2
Segments (Schedule of Other Information by Reportable Segment) (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Aug. 02, 2025
Aug. 03, 2024
Feb. 01, 2025
Segment Reporting, Asset Reconciling Item [Line Items]          
Total capital expenditures $ 175 $ 183 $ 341 $ 335  
Total depreciation and amortization 211 218 422 437  
Assets 15,253 15,624 15,253 15,624 $ 14,782 [1]
Domestic          
Segment Reporting, Asset Reconciling Item [Line Items]          
Total capital expenditures 161 160 311 298  
Total depreciation and amortization 201 208 402 417  
Assets 13,926 14,471 13,926 14,471 13,567
International          
Segment Reporting, Asset Reconciling Item [Line Items]          
Total capital expenditures 14 23 30 37  
Total depreciation and amortization 10 10 20 20  
Assets $ 1,327 $ 1,153 $ 1,327 $ 1,153 $ 1,215
[1] The Consolidated Balance Sheet as of February 1, 2025, has been condensed from the audited consolidated financial statements.